Sidoti et al. [142] investigated the association between polymorphisms of the enzymes PON1 (Q192R and L55M) and glyoxalase I (GI) (GI A111E) with the susceptibility to MS in 209 individuals with RRMS paired with 213 peoples clinically healthy. This evidence concerns the gene PON1 and myeloid sarcoma.